0001127602-15-021101.txt : 20150622 0001127602-15-021101.hdr.sgml : 20150622 20150622064702 ACCESSION NUMBER: 0001127602-15-021101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150618 FILED AS OF DATE: 20150622 DATE AS OF CHANGE: 20150622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULLIVAN LOUIS W CENTRAL INDEX KEY: 0001193522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 15943664 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN LOUIS DATE OF NAME CHANGE: 20020927 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-06-18 0001082554 UNITED THERAPEUTICS Corp UTHR 0001193522 SULLIVAN LOUIS W C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 Common Stock 2015-06-18 4 M 0 30000 41.14 A 30000 D Common Stock 2015-06-18 4 D 0 30000 185.78 D 0 D Common Stock 2015-06-18 4 M 0 15000 30.75 A 15000 D Common Stock 2015-06-18 4 S 0 15000 185.5982 D 0 D Share Tracking Award 41.14 2015-06-18 4 M 0 30000 0 D 2010-06-26 2019-06-26 Common Stock 30000 0 D Stock Options 30.75 2015-06-18 4 M 0 15000 0 D 2009-04-29 2018-04-29 Common Stock 15000 15000 D Exercise of a cash-settled share tracking award. Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. This transaction was executed in multiple trades at prices ranging from $185.25 to $186.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ John S. Hess, Jr. under Power of Attorney 2015-06-22